Women without risk factors for blood clots, venous thromboembolism (VTE), who are taking the third-generation oral contraceptive drospirenone found in YAZ, Yaz 28, Yazmin, Beyaz, Zarah, Gianvi, and Ocella have an increased risk for nonfatal blood clots, VTE, compared with women taking the second-generation contraceptive levonorgestrel, according to the findings of 2 new case-control studies.
Tags: AZ, Beyaz, Blood Clots, Dr. Mathews, Gianvi, new, Ocella, oral contraceptive, VTE, women, YAZ, Yaz 28, Yazmin, Zarah
Posted in Gynecology, News & Education, Our Blog | No Comments »
The US Food and Drug Administration (FDA) has approved a combination hormonal contraceptive tablet containing estradiol valerate and dienogest (Natazia; Bayer HealthCare Pharmaceuticals).
Tags: 4-Phaic, Bioidentical, estradiol, estradiol valerate, estrogen, European Union, kyle mathews, Natazia, oral contraceptive, Plano Ob Gyn Associates, synthetic estrogen, United States, women
Posted in Gynecology, News & Education | No Comments »